Antiproliferative activity of chelating N,O- and N,N-ruthenium(II) arene functionalised poly(propyleneimine) dendrimer scaffolds

被引：146
作者：
Govender, Preshendren [1 ]
Renfrew, Anna K. [2 ]
Clavel, Catherine M. [2 ]
Dyson, Paul J. [2 ]
Therrien, Bruno [3 ]
Smith, Gregory S. [1 ]
机构：
[1] Univ Cape Town, Dept Chem, ZA-7701 Cape Town, South Africa
[2] Ecole Polytech Fed Lausanne, Inst Sci & Ingn Chim, CH-1015 Lausanne, Switzerland
[3] Univ Neuchatel, Inst Chem, CH-2000 Neuchatel, Switzerland
来源：
DALTON TRANSACTIONS | 2011年 / 40卷 / 05期
基金：
英国医学研究理事会; 新加坡国家研究基金会;
关键词：
RUTHENIUM COMPLEXES; ANTICANCER ACTIVITY; MOLECULAR-STRUCTURE; CATALYTIC-ACTIVITY; RUTHENIUM(II)-ARENE COMPLEXES; NICKEL-CATALYSTS; METAL-COMPLEXES; ANTITUMOR DRUG; IN-VITRO; DNA;
D O I：
10.1039/c0dt00761g
中图分类号：
O61 [无机化学];
学科分类号：
070301 ; 081704 ;
摘要：
Chelating neutral (N,O) and cationic (N,N) first-and second-generation ruthenium(II) arene metallodendrimers based on poly(propyleneimine) dendrimer scaffolds were obtained from dinuclear arene ruthenium precursors by reactions with salicylaldimine and iminopyridyl dendritic ligands, respectively. The N, N cationic complexes were isolated as hexafluorophosphate salts and were characterised by NMR and IR spectroscopy, and MALDI-TOF mass spectrometry. Related mononuclear complexes were obtained in a similar manner and their molecular structures have been determined by X-ray diffraction analysis. The cytotoxicities of the mono-and multinuclear complexes were established using A2780 and A2780cisR human ovarian carcinoma cancer cell lines.
引用
收藏
页码：1158 / 1167
页数：10
相关论文
共 77 条
[31]   From bench to bedside -: preclinical and early clinical development of the anticancer agent indazolium trans-[tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019 or FFC14A) [J].
Hartinger, Christian G. ;
Zorbas-Seifried, Stefanie ;
Jakupec, Michael A. ;
Kynast, Bernd ;
Zorbas, Haralabos ;
Keppler, Bernhard K. .
JOURNAL OF INORGANIC BIOCHEMISTRY, 2006, 100 (5-6) :891-904
[32]   Bioorganometallic chemistry-from teaching paradigms to medicinal applications [J].
Hartinger, Christian G. ;
Dyson, Paul J. .
CHEMICAL SOCIETY REVIEWS, 2009, 38 (02) :391-401
[33]   Organometallic photonucleases: Synthesis and DNA-cleavage studies of cyclopentadienyl metal-substituted dendrimers designed to increase double-strand scission [J].
Hurley, AL ;
Mohler, DL .
ORGANIC LETTERS, 2000, 2 (18) :2745-2748
[34]   Antitumour metal compounds: more than theme and variations [J].
Jakupec, Michael A. ;
Galanski, Markus ;
Arion, Vladimir B. ;
Hartinger, Christian G. ;
Keppler, Bernhard K. .
DALTON TRANSACTIONS, 2008, (02) :183-194
[35]  
Jansen BAJ, 1999, EUR J INORG CHEM, P1429
[36]   Phase II studies of BBR3464, a novel tri-nuclear platinum complex, in patients with gastric or gastro-oesopliageal adenocarcinoma [J].
Jodrell, DI ;
Evans, TRJ ;
Steward, W ;
Cameron, D ;
Prendiville, J ;
Aschele, C ;
Noberasco, C ;
Lind, M ;
Carmichael, J ;
Dobbs, N ;
Camboni, G ;
Gatti, B ;
De Braud, F .
EUROPEAN JOURNAL OF CANCER, 2004, 40 (12) :1872-1877
[37]   Maltol-Derived Ruthenium-Cymene Complexes with Tumor Inhibiting Properties: The Impact of Ligand-Metal Bond Stability on Anticancer Activity In Vitro [J].
Kandioller, Wolfgang ;
Hartinger, Christian G. ;
Nazarov, Alexey A. ;
Bartel, Caroline ;
Skocic, Matthias ;
Jakupec, Michael A. ;
Arion, Vladimir B. ;
Keppler, Bernhard K. .
CHEMISTRY-A EUROPEAN JOURNAL, 2009, 15 (45) :12283-12291
[38]   From Pyrone to Thiopyrone Ligands-Rendering Maltol-Derived Ruthenium(II)-Arene Complexes That Are Anticancer Active in Vitro [J].
Kandioller, Wolfgang ;
Hartinger, Christian G. ;
Nazarov, Alexey A. ;
Kuznetsov, Maxim L. ;
John, Roland O. ;
Bartel, Caroline ;
Jakupec, Michael A. ;
Arion, Vladimir B. ;
Keppler, Bernhard K. .
ORGANOMETALLICS, 2009, 28 (15) :4249-4251
[39]   Mono- and polynuclear [alkylamine]platinum(II) complexes of [1,2-Bis(4-fluorophenyl)ethylenediamine]platinum(II): Synthesis and investigations on cytotoxicity, cellular distribution, and DNA and protein [J].
Kapp, T ;
Dullin, A ;
Gust, R .
JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (03) :1182-1190
[40]   Ruthenium complexes as anticancer agents [J].
Kostova, I .
CURRENT MEDICINAL CHEMISTRY, 2006, 13 (09) :1085-1107
12345678